Controversial US-backed vaccine trial in African newborns halted
- The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.
- It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.
- ”The minister of health in Guinea-Bissau, Quinhin Nantote, previously denied that the project would move forward.
Unverified
- The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday.
- It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.
- ”The minister of health in Guinea-Bissau, Quinhin Nantote, previously denied that the project would move forward.
Sources: Guardian